EXPERTS Act of 2025

Bill Number

H.R. 6145

Origin Chamber

House

Congress

119th Congress, Session 1

Policy Area

Government Operations and Politics

Status

Introduced

Latest Action

2025-11-19: Referred to the Committee on the Judiciary, and in addition to the Committee on Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Last Updated

2026-06-04T08:08:48Z

AI-Generated Summary

Purpose of the Legislation

The EXPERTS Act of 2025 aims to enhance transparency, accountability, and public participation in the federal rulemaking process. It seeks to protect the expertise of executive agencies in implementing broad congressional statutes, address conflicts of interest from industry-funded research, prioritize public health and equity in regulatory decisions, and streamline administrative reviews while limiting undue political interference.

Key Provisions

• Findings and Sense of Congress (Secs. 2-3): Affirms Congress's reliance on agency discretion for broad regulatory statutes, especially for unforeseen issues like technological changes. It states that rules should not be invalidated solely for lacking specific congressional language or prior agency precedent. Agencies should better account for public health benefits, social equity (fair distribution of rule impacts across groups), and congressional intent in analyses, rather than overemphasizing industry costs.

• Disclosure of Conflicts of Interest (Secs. 4-5): Amends the Administrative Procedure Act (APA, 5 U.S.C. §553) to require anyone submitting scientific, economic, or technical studies during public comments to disclose funding sources, reviewers, and financial ties if the submitter funded the work directly or indirectly. Agencies must make these studies and any identified conflicts publicly available (e.g., on websites and dockets) unless protected by privacy laws (FOIA exemptions). Conflicts include funding over 10% from regulated entities or their involvement in reviewing the work.

• Penalties for False Submissions (Sec. 10): Public companies (those filing annual reports with the SEC) face civil penalties of at least $250,000 for first violations and $1,000,000 for subsequent ones if they submit knowingly false or misleading comments. Such submissions can be excluded from agency consideration without affecting judicial deference to the final rule.

• Transparency in Regulatory Review (Secs. 6-7, 9): Agencies must disclose changes to proposed rules made during review by the Office of Information and Regulatory Affairs (OIRA, part of OMB) and explain if influenced by OIRA, other agencies, or officials. Withdrawn rules require public justification, including any external input. OIRA reviews of significant rules (those with major economic or policy impacts) are limited to 60 days, with a one-time 30-day extension requiring public justification; agencies can proceed without OIRA approval if timelines are missed.

• Negotiated Rulemaking Changes (Sec. 8): Limits negotiated rulemaking (collaborative rule development) to intergovernmental processes involving federal, state, local, and tribal governments, excluding private parties. Includes technical amendments repealing or modifying related provisions in various laws (e.g., education, health, housing acts).

• Office of the Public Advocate (Sec. 11): Establishes this new office in OMB, led by a Senate-confirmed National Public Advocate with expertise in consumer protection or administrative law. Duties include aiding public participation, researching equity impacts, conducting equity assessments (evaluations of how rules affect protected groups like racial minorities or low-income communities), and improving outreach (e.g., multilingual notices, partnerships with local groups).

• Judicial Review and Deference (Secs. 12-13): Codifies deference to reasonable agency interpretations of ambiguous statutes if procedures are followed, regardless of the rule's significance (reinforcing principles like Chevron deference, where courts defer to agencies on statutory ambiguity). Defines "unreasonable delay" in rulemaking (e.g., over 1 year without action) as arbitrary and capricious. Sets a 6-year statute of limitations for challenging agency actions in court.

• Public Participation Enhancements (Secs. 14-15): Agencies must promote awareness of rulemakings via notifications, websites, and social media within 2 days of publication, and maintain logs of participants. Petitions for rulemaking with over 100,000 signatures require a response within 60 days. Agencies must create procedures for petitions, including public education and online dockets.

• Congressional Review Act (CRA) Amendment (Sec. 16): Removes the requirement for agencies to submit rules to Congress before publication, simplifying the process.

• Reinstatement of Disapproved Rules (Sec. 17): Allows agencies to fast-track reinstatement of rules previously nullified by Congress under the CRA within 1 year of enactment; after that, standard APA procedures apply.

• Cost-Benefit and Equity Requirements (Sec. 18): Agencies must consider non-quantifiable public benefits (e.g., health protections) and distributional effects (how rules impact different groups) in analyses, prioritizing rules that benefit the public. Courts cannot invalidate rules for failing cost-benefit tests unless explicitly required by law.

• Definitions (Sec. 19): Clarifies terms like "social equity impact" (disproportionate effects on protected classes based on data) and "significant regulatory action" (rules with $100M+ economic effects or major policy implications).

Significant Changes to Existing Law

• APA Amendments (5 U.S.C. §§553, 706): Introduces mandatory disclosures for funded research in comments, public availability requirements, and penalties—previously, such transparency was voluntary or limited. Codifies broad deference to agencies, potentially reversing recent Supreme Court limits on Chevron deference. Adds timelines for public responses to petitions and awareness efforts.

• OIRA Review (Exec. Order 12866 integration): Imposes strict 60/90-day limits on reviews, with automatic agency proceed-if-not-reviewed—previously, OIRA had unlimited time, often delaying rules.

• Negotiated Rulemaking (5 U.S.C. Subchapter III): Restricts to governments only, removing private sector involvement and repealing mandates in over a dozen statutes (e.g., Higher Education Act, Affordable Care Act), shifting to standard notice-and-comment processes.

• CRA (5 U.S.C. §801): Eliminates pre-publication submission to Congress, reducing procedural hurdles but potentially weakening congressional oversight.

• Judicial Review (5 U.S.C. Chapter 7): New 6-year limit on challenges (previously 6 years under general law but often shorter via laches); explicitly protects against delay-based challenges unless good cause shown.

Potential Impacts

• Government Agencies: Increases administrative burdens for disclosures, equity assessments, and public outreach but streamlines OIRA reviews and protects agency expertise from reversals. Could reduce delays in issuing protective rules (e.g., environmental or health standards) while requiring more equity focus, potentially slowing some processes.

• Citizens: Enhances access through better notifications, petition responses, and the Public Advocate office, empowering underrepresented groups (e.g., via equity analyses). May lead to fairer rules addressing social disparities but could limit private industry input in negotiations.

• International Relations: Minimal direct impact; focuses on domestic rulemaking. Indirectly, faster, more transparent U.S. regulations could improve global perceptions of U.S. governance in areas like trade or environmental standards.

Main Stakeholders Affected

• Federal Agencies and OIRA/OMB: Must implement new disclosures, timelines, and equity duties; gain deference but face penalties for non-compliance.
• Public and Civil Society (Individuals, NGOs, Community Groups): Benefit from expanded participation, awareness, and equity protections, especially protected classes (e.g., racial minorities, low-income, rural communities).
• Industry and Public Companies: Face stricter disclosure and penalty rules for comments; limited role in negotiated rulemaking may reduce influence, but transparency could level the playing field.
• Congress and Courts: Reduced CRA submission eases oversight but codifies deference, shifting interpretive power to agencies; 6-year review limit streamlines litigation.
• State, Local, and Tribal Governments: Retain key role in negotiated rulemaking; gain from intergovernmental transparency and equity outreach.

Notable Legal, Constitutional, or Political Implications

• Legal: Reinforces agency autonomy under the APA by codifying deference to interpretations of ambiguous laws, potentially insulating rules from judicial invalidation (countering recent cases like Loper Bright limiting Chevron). The 6-year statute of limitations standardizes challenges, reducing uncertainty from varying court doctrines. Equity assessments introduce procedural safeguards against bias, akin to environmental impact statements.

• Constitutional: Aligns with due process (5th Amendment) by enhancing public notice and participation, ensuring rulemaking is not arbitrary. May raise separation-of-powers questions by limiting executive (OIRA) and congressional (CRA) interference, emphasizing agency roles under broad statutes.

• Political: Politically progressive tilt via equity focus and public prioritization, potentially curbing industry "capture" of regulations. Could polarize along partisan lines—supporters see it as protecting expertise against reversals (e.g., environmental rollbacks); critics may view it as entrenching bureaucracy. Establishes a new advocate office, increasing OMB's role in equity without new funding mandates.

This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.

Sponsor

Rep. Jayapal, Pramila [D-WA-7]

Cosponsors (74)

Rep. Adams, Alma S. [D-NC-12], Rep. Amo, Gabe [D-RI-1], Rep. Ansari, Yassamin [D-AZ-3], Rep. Balint, Becca [D-VT-At Large], Rep. Beatty, Joyce [D-OH-3], Rep. Bonamici, Suzanne [D-OR-1], Rep. Boyle, Brendan F. [D-PA-2], Rep. Brownley, Julia [D-CA-26], Rep. Carson, André [D-IN-7], Rep. Casar, Greg [D-TX-35], Rep. Chu, Judy [D-CA-28], Rep. Clarke, Yvette D. [D-NY-9], Rep. Cohen, Steve [D-TN-9], Rep. Correa, J. Luis [D-CA-46], Rep. Dean, Madeleine [D-PA-4], Rep. DeLauro, Rosa L. [D-CT-3], Rep. Deluzio, Christopher R. [D-PA-17], Rep. DeSaulnier, Mark [D-CA-10], Rep. Dexter, Maxine [D-OR-3], Rep. Dingell, Debbie [D-MI-6], Rep. Espaillat, Adriano [D-NY-13], Rep. Evans, Dwight [D-PA-3], Rep. Foushee, Valerie P. [D-NC-4], Rep. Frost, Maxwell [D-FL-10], Rep. Garcia, Robert [D-CA-42], Rep. García, Jesús G. "Chuy" [D-IL-4], Rep. Garcia, Sylvia R. [D-TX-29], Rep. Hayes, Jahana [D-CT-5], Rep. Horsford, Steven [D-NV-4], Rep. Huffman, Jared [D-CA-2], Rep. Jackson, Jonathan L. [D-IL-1], Rep. Johnson, Henry C. "Hank" [D-GA-4], Rep. Khanna, Ro [D-CA-17], Rep. Krishnamoorthi, Raja [D-IL-8], Rep. Lee, Summer L. [D-PA-12], Rep. Levin, Mike [D-CA-49], Rep. Lieu, Ted [D-CA-36], Rep. Lynch, Stephen F. [D-MA-8], Rep. Magaziner, Seth [D-RI-2], Rep. McBath, Lucy [D-GA-6], Rep. McClellan, Jennifer L. [D-VA-4], Rep. McCollum, Betty [D-MN-4], Rep. McGovern, James P. [D-MA-2], Rep. McIver, LaMonica [D-NJ-10], Rep. Nadler, Jerrold [D-NY-12], Del. Norton, Eleanor Holmes [D-DC-At Large], Rep. Omar, Ilhan [D-MN-5], Rep. Pingree, Chellie [D-ME-1], Rep. Pocan, Mark [D-WI-2], Rep. Quigley, Mike [D-IL-5] and 24 more

Recent Actions

• 2025-11-19: Referred to the Committee on the Judiciary, and in addition to the Committee on Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
• 2025-11-19: Referred to the Committee on the Judiciary, and in addition to the Committee on Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
• 2025-11-19: Introduced in House
• 2025-11-19: Introduced in House

Bill Versions

• Experts Protect Effective Rules, Transparency, and Stability Act of 2025 — issued 2025-11-19 — PDF (36 pages)

Related Bills

• S. 3210 (119th Congress)